Introducing My Age F: A New Test for Assessing Pregnancy Potential

A Breakthrough in Reproductive Health: My Age F

On September 9, 2025, TL Genomics, based in Fujisawa, Kanagawa, will officially launch a revolutionary test called "My Age F." This innovative product aims to assess women’s pregnancy potential numerically, offering those struggling with infertility a new perspective in planning their families. Alongside the launch, a press conference will be held in Tokyo to share insights about this groundbreaking technology.

Understanding the Context of Infertility

According to the National Institute of Population and Social Security Research, one in four couples has experienced infertility testing or treatment, with two in five couples concerned they may have fertility issues. The trend of later marriages has intensified anxiety among women regarding their ability to conceive. Consequently, there’s a pressing demand for timely and effective treatment options. Traditional AMH testing, while measuring the number of eggs, falls short in evaluating actual pregnancy potential. The reality is complex; some women may have many eggs but still struggle to conceive, while others may have fewer eggs and successfully become pregnant.

Collaborative Development with Leading Institutions

The concept for My Age F originated from the personal experiences of TL Genomics representative, Tomohiro Kubo, whose wife faced a high-risk pregnancy. To address this, TL Genomics partnered with the National Cerebral and Cardiovascular Center to develop a new technology called SinChro™, which measures chromosomal aging. Furthermore, a study conducted with Osaka Metropolitan University confirmed the test's correlation with natural conception success among 500 female participants.

My Age F allows women to assess their overall aging and pregnancy potential from the comfort of their homes through a simple blood sample. This empowerment helps them gauge their current fertility and facilitates strategic planning for family growth alongside their careers. The product aims to provide women with the tools they need to take control of their reproductive futures.

How to Use My Age F

Acquiring and using the My Age F testing kit is simple and user-friendly:
1. Purchase the Kit: Visit the official website (tlgenomics.com) to order your test kit starting from September 9.
2. Self-Collection: Collect a drop of blood from your fingertip.
3. Return Sample: Mail the collected sample to the lab.
4. Receive Results: Expect an email notification with your results within approximately one week.

Additionally, testing is available at partner clinics, where expert counseling services are offered. Locations such as Medical Park Minato Mirai in Yokohama and Marunouchi no Mori Ladies Clinic in Chiyoda, Tokyo, will provide these services.

Our Mission

The launch of My Age F aligns with TL Genomics' objective to create a society where everyone who wishes to have children can achieve that goal. By supporting women and couples who harbor uncertainties about their futures, TL Genomics is committed to facilitating the freedom to make informed choices. The company aims to seamlessly integrate research and social implementation, leveraging Japanese technology to introduce convenience and joy into people’s lives.

On the same day of the launch, the press conference at Shinagawa will feature insights from Kubo regarding the technological advancements behind My Age F and its future implications for reproductive health.

Company Background

Company Name: TL Genomics Co., Ltd.
Website: tlgenomics.com
CEO: Tomohiro Kubo
Location: 2020-5 Endo, Fujisawa, Kanagawa
Established: January 2015
Core Business: Development of diagnostic tests related to bone marrow transplants, chromosomal analysis for disease risk, and pregnancy potential evaluation through products like My Age and My Age F.